FemPulse Receives FDA IDE Approval for the Pivotal Clinical Trial of its Wearable Bioelectronic Device for Overactive Bladder in Women
December 11, 2024 15:18 ET
|
FemPulse
SAN FRANCISO, Dec. 11, 2024 (GLOBE NEWSWIRE) -- FemPulse™ announced today Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to begin its EVANESCE II...
Eclipse Foundation Introduces Open Collaboration Tools (OCT) to Transform Remote Development
December 05, 2024 07:00 ET
|
Eclipse Foundation Canada
BRUSSELS, Dec. 05, 2024 (GLOBE NEWSWIRE) -- The Eclipse Foundation, one of the world’s largest open source software foundations, today announced the creation of the Eclipse Open Collaboration Tools...
Eclipse Foundation Introduces Theia IDE to Elevate the Modern Developer Experience
June 27, 2024 07:00 ET
|
Eclipse Foundation Canada
BRUSSELS, Belgium, June 27, 2024 (GLOBE NEWSWIRE) -- The Eclipse Foundation, one of the world’s largest open source foundations, has announced the release of Eclipse Theia IDE, marking a significant...
Agricultural Wastewater Treatment Market Revenues to Reach USD 3.02 billion by 2028 - Market Size, Share, Forecasts, & Trends Analysis Report by Mordor Intelligence
August 03, 2023 09:30 ET
|
Mordor Intelligence
Hyderabad, Aug. 03, 2023 (GLOBE NEWSWIRE) -- According to a new market research report titled "Agricultural Wastewater Treatment Market Report (2023-2028)," the market is estimated at USD 2.40...
RenovaCare Establishes Leadership Position in Cell Isolation and Spray Technology with Newly Awarded U.S. Patent
October 14, 2021 08:30 ET
|
RenovaCare, Inc.
SCOTTSDALE, Ariz., Oct. 14, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented cell therapy technologies for the regeneration of skin and tissues,...
Gitpod Enables Every Developer to Run Upstream VS Code in a Browser
September 28, 2021 07:00 ET
|
Gitpod Inc.
SAN FRANCISCO, Sept. 28, 2021 (GLOBE NEWSWIRE) -- Gitpod, the leading open source platform for automated dev environments, today announced that they have created a new open source project (licensed...
FDA Grants RenovaCare Full IDE Approval for Safety and Feasibility Clinical Trial
May 06, 2021 08:30 ET
|
RenovaCare, Inc.
ROSELAND, N.J., May 06, 2021 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), today announced that its Investigational Device Exemption (IDE) application has been granted...
Gitpod Raises $3M USD Seed Funding, Announces Native Integration with GitLab
October 08, 2020 09:00 ET
|
Gitpod Inc.
KIEL, Germany, Oct. 08, 2020 (GLOBE NEWSWIRE) -- Gitpod, the first open source developer platform to automate the provisioning of ready-to-code development environments, today announced $3M USD seed...
Gitpod Fundamentally Changes Development Workflows with the Industry’s First Open Source Solution for Automated, Pre-built Dev Environments
August 25, 2020 09:00 ET
|
TypeFox GmbH
KIEL, Germany, Aug. 25, 2020 (GLOBE NEWSWIRE) -- Gitpod, providers of automated dev environments, today announced that they have open sourced a new class of cloud-based IDE that fundamentally...
RenovaCare Receives FDA Conditional IDE Approval of CellMist™ System and SkinGun™ Device, Enabling Clinical Study for Safety and Feasibility
August 11, 2020 08:30 ET
|
RenovaCare, Inc.
ROSELAND, N.J., Aug. 11, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration...